Gerresheimer (GXI) PT Set at €49.50 by JPMorgan Chase & Co.

Gerresheimer (ETR:GXI) received a €49.50 ($57.56) target price from JPMorgan Chase & Co. in a report released on Tuesday. The firm currently has a “sell” rating on the stock. JPMorgan Chase & Co.‘s price objective suggests a potential downside of 14.80% from the company’s current price.

A number of other equities analysts also recently commented on the stock. Berenberg Bank set a €81.00 ($94.19) price objective on shares of Gerresheimer and gave the stock a “buy” rating in a research report on Friday, November 23rd. Hauck & Aufhaeuser set a €55.00 ($63.95) price objective on shares of Gerresheimer and gave the stock a “neutral” rating in a research report on Monday, October 15th. Deutsche Bank set a €86.00 ($100.00) price objective on shares of Gerresheimer and gave the stock a “buy” rating in a research report on Tuesday, January 15th. Credit Suisse Group set a €82.00 ($95.35) price objective on shares of Gerresheimer and gave the stock a “buy” rating in a research report on Tuesday, February 5th. Finally, Goldman Sachs Group set a €65.00 ($75.58) price objective on shares of Gerresheimer and gave the stock a “neutral” rating in a research report on Monday. Two equities research analysts have rated the stock with a sell rating, six have issued a hold rating and four have issued a buy rating to the company. The company presently has a consensus rating of “Hold” and an average price target of €68.77 ($79.97).

ETR:GXI traded up €1.35 ($1.57) during trading hours on Tuesday, reaching €58.10 ($67.56). 136,855 shares of the company’s stock were exchanged, compared to its average volume of 140,925. Gerresheimer has a 1-year low of €59.97 ($69.73) and a 1-year high of €78.25 ($90.99).

About Gerresheimer

Gerresheimer AG manufactures and sells specialty glass and plastic products primarily for the pharma and healthcare industry worldwide. It operates through two divisions, Plastics & Devices, and Primary Packaging Glass. The Plastics & Devices division offers drug delivery systems, including inhalers, pen systems, and injection systems; sterile and non-sterile prefillable syringe systems for the pharmaceutical and biotech industries; and disposables for various analysis systems that are used in laboratories and medical practices, quick tests for patients in medical practices or hospitals, skin-prick aids and lancets for diabetics, disposables and components for dialysis machines, and catheters and surgical devices.

Further Reading: How to Track your Portfolio in Google Finance

Analyst Recommendations for Gerresheimer (ETR:GXI)

Receive News & Ratings for Gerresheimer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Gerresheimer and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply